{site_meta && site_meta.display_name} Logo

Reportable

Cut through the daily deluge of information from news, social media and scientific literature to better communicate to your audiences, monitor and measure your business reputation and keep a close eye on your competition.

RSS Feed for Reportable

NY CRE & CONTRACTORS FOR TUNNEL TO TOWERS ANNOUNCES FIFTH ANNUAL COCKTAIL TRIBUTE

September 10, 2025 — NEW YORK, NY (September 10, 2025) – The New York Commercial Real Estate & Contractors for Tunnel to Towers (NY CRE & Contractors for T2T), an exclusive philanthropic group supporting the Tunnel to Towers Foundation, is proud to announce its Fifth Annual Cocktail Tribute, set for Thursday, October 16, 2025, at Redeye Grill in Midtown Manhattan. This year’s honoree is Bill Dacunto, Executive Vice President of Silverstein Properties, recognized for his unwavering dedication to the men and women who serve our nation and communities.

Holiday shoppers to spend 6 percent more this season; use AI for inspiration and quality deals

September 4, 2025 — Boston, MA – September 2025 – Holiday shoppers are expected to spend at least 6 percent more, or up to $1,077 per household, compared to last year, according to Simon-Kucher’s highly anticipated 7th Annual Holiday Shopping Report, which provides data-driven insights and explores consumer retail macroeconomic trends. Consumers report stricter budgets and a shift toward quality and value over price in most categories.

Aix Marseille Université (amU) and InFlectis BioScience Expand Therapeutic Promise of IFB-088 to Axonal Forms of Charcot-Marie-Tooth Disease

September 3, 2025 — Nantes, France – September 2nd, 2025 – InFlectis BioScience, a pioneering biotech company advancing treatments that modulate the Integrated Stress Response (ISR), announces a major milestone in the development of its lead compound IFB-088, now demonstrating efficacy in an animal model of the most prevalent form of axonal Charcot-Marie-Tooth disease, CMT-2A. Until now, InFlectis had established proof of concepts for IFB-088 in animal models of demyelinating CMTs, including CMT1A and CMT1B.

Prophesee Brings Event-Based Vision to Raspberry Pi 5 with GenX320 Starter Kit

August 26, 2025 — Paris, France – August 26, 2025 – Prophesee, the inventor and leader in event-based neuromorphic vision systems, today announces the launch of the GenX320 Starter Kit for Raspberry Pi 5, making its breakthrough frameless sensing technology available to the Raspberry Pi® developer community for the first time. Built around Prophesee’s ultra-compact, ultra-efficient GenX320 event-based vision sensor, the kit connects directly to the Raspberry Pi 5 camera connector to allow development of real-time applications that leverage the advantages of event-based vision for drones, robotics, industrial automation, surveillance, and more.

Wendt Partners Becomes First HubSpot Elite Partner to Join Profoundly (www.profound.ly)

August 22, 2025 — New York, NY (August 22, 2025) – Wendt Partners, an award-winning HubSpot Elite Solutions Partner headquartered in New York City, announced today that the firm has become the first elite-tier partner in the global HubSpot community to join Profoundly, the world’s first online talent marketplace specifically designed to connect customers and providers in the HubSpot ecosystem. Co-founded by Jason Azocar, former CEO of HubSearch, and Brian Garvey, formerly Senior Vice President of HubSpot’s Worldwide Solutions Partner Ecosystem, the Profoundly platform has rapidly become recognized as the premier go-to resource for matching HubSpot customers with HubSpot experts, ranging from freelancers and solo practitioners up to full-service solution partners and agencies.

Sethera Therapeutics Unveils Breakthrough Enzymatic Platform for Next-Generation Peptide Drugs

August 21, 2025 — SALT LAKE CITY, Utah August 21, 2025 — Sethera Therapeutics today announced publication in the Proceedings of the National Academy of Sciences (PNAS) of peer-reviewed results describing an enzymatic crosslinking platform that forges durable thioether “staples,” locking peptides into drug-like cyclic architectures. The platform works across a broad range of substrates, including sequences built entirely from non-natural building blocks, delivering exceptional versatility, expanding accessible chemical space, and enabling the design of next-generation peptide therapeutics.

Adelaide Perez Brings Ocean Beauty to the Canvas

August 20, 2025 — Who is Adelaide Janet Perez? At just 17, Adelaide Janet Perez is already making waves (pun absolutely intended) with her paintings — vivid, emotional works that blend realism with a deep love for nature.

BioMed X and Novo Nordisk Launch New Collaboration in Oral Peptide Drug Delivery

August 19, 2025 — Heidelberg, Germany, August 19, 2025 – BioMed X, an independent biomedical research institute based in Heidelberg, Germany, announced today the launch of a new collaboration with Novo Nordisk, a leading global healthcare company headquartered in Denmark. This partnership aims to address one of the most critical challenges in modern drug development: the efficient oral delivery of therapeutic peptides.